-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the research and development and application of biosimilar drugs has increased
.
Clinical pharmacology research is an important content in the comparison of biosimilar drugs, and it is very important to support the similarity evaluation of the effectiveness and safety of biosimilar drugs and reference drugs
We sincerely welcome valuable comments and suggestions from all walks of life on the solicitation draft, and timely feedback to us for follow-up improvement
.
The time limit for soliciting opinions is 1 month from the date of publication
Please send your feedback to the mailbox of the following contact:
Contact: Wang Yuzhu; Li Jian
Contact: wangyzh@cde.
Thank you for your participation and great support
Drug Evaluation Center of the State Drug Administration
July 8, 2021
attachment1 : | "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)". |
Annex 2: | Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Comment)". |
Annex 3 : | "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form. docx |
pdf Annex 2: Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
pdf Annex 3: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form.
docx Annex 1: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
pdf Annex 1: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
pdf "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
pdf Annex 2: Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
pdf Annex 2: Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Comment)".
pdf Drafting Instructions for "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)".
pdf Annex 3: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Comment)" feedback form.
docx Annex 3: "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form.
docx "Technical Guidelines for Clinical Pharmacology Research of Biosimilar Drugs (Draft for Solicitation of Comments)" feedback form.
docx